Call for Abstracts

If you are a TTS Member we have setup an account for you in the system. You can retrieve your login credentials in the TTS Members area of tts.org. We will be emailing our members their login credentials for TTS 2020 within the next 24 hours, stay tuned!

Call for Abstract Highlights

  • Submission deadline: February 18, 2020.
  • Notification of acceptance: May 4, 2020.
  • Registration: presenters must be registered and paid by May 18, 2020; otherwise the abstract will be removed from the program.
  • Rule of two: one presenter can present maximum two abstracts during the Congress. Co-authors must be assigned as presenter if more than two abstracts were accepted (see details below).
  • Resubmission policy: An abstract that has been previously published or presented at a national, regional or international meeting can only be submitted provided that there are new methods, findings, updated information or other valid reasons for submitting.

Please find below instructions to read before opening the submission page.

Abstract Submission Process

The deadline to submit the abstract(s) is February 18, 2020. The submitting author will receive notification of acceptance by May 4, 2020. At the time of the confirmation of acceptance of your abstract, presenters will be requested to register for the congress. Deadline for abstract confirmation of acceptance and presenter registration is May 18, 2020.

Choosing a Track Category

During the submission process, you will be asked to select one track category for your abstract. The track category is the general theme under which the abstract will be reviewed and later assigned and published in the congress materials (if accepted).

Abstract Structure

Abstracts in all tracks should be structured chronologically in five sections: first Introduction; then Materials and Methods, Results, and Discussion and finally, Conclusion.

  • The Introduction section clarifies the motivation for the work presented and prepares readers for the structure of the paper.
  • The Materials and Methods section provides sufficient detail for other scientists to reproduce the experiments presented in the paper. In some journals, this information is placed in an appendix, because it is not what most readers want to know first.
  • The Results and Discussion sections present and discuss the research results, respectively. They are often usefully combined into one section, however, because readers can seldom make sense of results alone without accompanying interpretation — they need to be told what the results mean.
  • The Conclusion section presents the outcome of the work by interpreting the findings at a higher level of abstraction than the Discussion and by relating these findings to the motivation stated in the Introduction. Explain the significance of your findings / outcomes and future implications of the results.

Please do not insert tables into the body of the abstracts. They will need to be uploaded into jpg, png or gif as a figure.

Abstract Guidelines

All abstracts must be submitted electronically through the Congress management system.

  • Abstracts will be accepted in English only.
  • There is no fee for submitting an abstract.
  • The abstract text body is limited to 3,000 characters including spaces. A maximum of four figures (in JPG, GIF or PNG with ideally 600 dpi) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups. File size of 2 MB maximum for each figure.
  • ONLY accepted abstracts with presenter registered to the Congress will be published in an online supplement of the Transplantation Journal. Abstracts will also be posted prior to the event on the Congress website.
  • Ensure that all co-authors approve of the abstract submission, publication, and potential presentation.
  • Disclosure: abstract presenter will be required to disclose any conflict of interest upon acceptance and on the first slide of presentation.
  • Presenter must confirm and register to the Congress by the registration early bird deadline, otherwise the abstract will not be published and will be removed from the program.
  • Employees of Commercial Interests: TTS recognizes that employees of commercial interests are often involved in research and discovery and encourages these employees to submit abstracts to facilitate the flow of new information. Employees of commercial interests should submit abstracts when the content is limited to basic science research (e.g., pre-clinical research, drug discovery) or the processes/methodologies of research, themselves unrelated to a specific disease or compound/drug, and the abstract is not related to clinical applications of the research/discovery or clinical recommendations concerning the business lines or products of their employer.
  • Abstracts from employees of commercial interests that are selected for oral or poster presentation will be subject to an additional rigorous review to guard against presentation of content that is related to clinical recommendations concerning the business lines or products of the employer.

Policies for Abstract Submission

Copyright Policy

Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

Resubmission Policy

An abstract that has been previously published or presented at a national, regional or international meeting can only be submitted provided that there are new methods, findings, updated information or other valid reasons for submitting.

Plagiarism

TTS regard plagiarism as serious professional misconduct. All abstracts are screened for plagiarism and when identified, the abstract and any other abstracts submitted by the same author are rejected. In addition, the submitting author’s profile and scholarship application, in the case one has been submitted, will also be cancelled.

Organ Trafficking and Tourism Ethics Compliance

To be eligible to submit and abstract, you must disclose that the author(s)/ scientist(s) have not violated any aspect of the following Ethics Statement:

Abstract Review and Selection Process

Abstract Review
  • All submitted abstracts will go through a blinded peer-review process carried out by an international review committee.
  • All abstracts will be reviewed (blinded) by at least three international referees, selected by the Organizing Committee.
  • Abstracts which do not meet the focus of the topic category as requested by the authors will be reassigned to another category.
Format of Presentation

You may opt to submit your abstract to be considered for an oral/mini-oral presentation, campfire presentation, poster presentation, or either oral/poster (at the committee’s discretion). If your abstract is accepted as an “oral”, it can be assigned to a full oral presentation, a shorter mini-oral or an interactive campfire discussion.

Rule of Two

Each presenting author may present a maximum of two abstracts at the congress: two orals or two posters or one oral and one poster. The number of submissions is however not limited. Should an author have more than two abstracts accepted, a co-author must be named as presenting author for one or more abstracts. Should an author have more than two abstracts accepted for oral or poster presentation, a co-author must be named as presenting author for one or more abstracts. All presenting authors must register and attend the congress.